Articles

‘We’re globally living in a twilight.’ Why oil can’t catch a bid, and stocks may remain rangebound, strategist says

Victor Shvets, the global head of desk strategy for Macquarie Capital and author of a book that compares the current global fractures to the 1930s, says right now is a period of “twilights” without recessions or sharp recoveries.

How Michael Jordan’s $15 million Chicago home landed at the center of a TikTok controversy

After languishing 12 years on the market, the former NBA star’s largely abandoned property is getting attention again.

Apple and Nvidia in talks to invest in OpenAI: report

Apple and Nvidia are reportedly in talks to participate in a multi-billion dollar fundraising round led by Thrive Capital that would see them invest in OpenAI alongside Microsoft

Why hasn’t Kamala Harris already executed her economic plans? U.S. first had to recover from COVID, she says.

Democratic presidential nominee Kamala Harris on Thursday offered a response to the criticism that she already should have implemented some of her economic proposals, with her remarks coming in a much-anticipated interview with CNN’s Dana Bash.

Dell is back in Wall Street’s favor, showing profit and big growth in AI servers

Dell Technologies Inc. should be back in Wall Street’s good graces after Thursday’s fiscal second-quarter results showed that it can post solid profits in AI servers — a big turnaround from the previous quarter.

These tips for investing in mutual funds and ETFs cushion you against the market

Earnings season ends, Fed easing begins, and why it makes sense to look outside of the U.S. market.

This small-cap ETF has lured investors after Fed’s nod to rate cuts. Can it keep it up?

In this week’s ETF Wrap, we look at small-cap stocks and funds, which many investors think are due for a rebound after Federal Reserve Chair Jerome Powell finally set the table for interest-rate cuts ahead.

Trump proposes that U.S. government or insurers cover all costs for IVF

Republican presidential nominee Donald Trump on Thursday rolled out a new proposal aimed at people relying on in vitro fertilization. Democrats have criticized Trump over the challenges faced by IVF doctors and patients in the wake of the Supreme Court’s 2022 Dobbs decision.

How prices for the U.S. Open’s ‘Honey Deuce’ — now $23 — stack up against inflation

Prices for the famous tennis cocktail have been raised six times since 2012.

Lululemon shares fall as athleisure retailer cuts outlook

Shares of Lululemon Athletica fell after hours on Thursday after the yoga-wear maker and retailer cut its full-year outlook, further fueling Wall Street’s worries that the years-long trend toward athleisure has run its course.

Ulta Beauty’s same-store sales take a surprising turn, and retailer’s stock drops 8%

Shares of Ulta Beauty Inc. dropped more than 8% in the extended session Thursday after the specialty retailer reported worse-than-expected quarterly earnings, cut its guidance, and showed a drop in same-store sales against expectations of an increase.

Marvell’s stock climbs as earnings report brings an improved growth forecast

The semiconductor company is benefiting from AI traction and expects growing operating leverage.
1 921 922 923 924 925 2,415